Meghan McGarry | UCSF Profiles

Meghan McGarry, MD, MS

Title	Assistant Professor
Institution	University of California San Francisco
Department	Pediatrics
Address	550 16th. Street San Francisco CA 94158
Phone	415-476-3334
vCard	Download vCard

Biography

Education and Training

Whitworth College	BS Biology	2005
University of Washington	M.D.	2009
Rainbow Babies and Children's Hospital	Pediatric Residency	2012
University of California San Francisco	Pediatric Pulmonology	2015
University of California San Francisco	Masters Clinical Research	2015

Awards and Honors

NHLBI	2018 -	2023	K23 Career Development Award
Cystic Fibrosis Foundation	2016 -	2019	Harry Schwachman Cystic Fibrosis Clinical Scholar
UCSF	2017		Jane Addams Social Justice Award
American Thoracic Society	2016		ATS International Conference Pediatric Abstract Scholarship
NICHD/NIGMS	2013 -	2016	Pediatric Clinical Pharmacology, Drug Action, and Pharmacogenetics T32
California Thoracic Society	2015		Best Research, Fellows Poster Presentation
Breathe California	2015		Walter Travel Grant
American Thoracic Society	2014		ATS International Conference Pediatric Abstract Scholarship
California CF Consortium	2014		Fellow’s Scholarship
California CF Consortium	2013		Fellow’s Scholarship
Rainbow Babies and Children’s Hospital	2010		Resident Teacher of the Year

Overview

Dr. McGarry is a Pediatric Pulmonologist who researches cystic fibrosis. Her main focus is researching health disparities in cystic fibrosis, particularly in minorities. She is conducting a cohort study of lung function in Latinos/Hispanics with cystic fibrosis. She also does research in diversity in clinical trials in cystic fibrosis.

Dr. McGarry studied Biology at Whitworth College. She then attended University of Washington School of Medicine, working in many underserved regions from Alaska to Zambia. She completed her Pediatric residency at Rainbow Babies and Children's Hospital. She completed her Pediatric Pulmonary and Pediatric Clinical Pharmacology Fellowships at University of California San Francisco. She also completed her Masters in Clinical Research at University of California San Francisco.

Interests

Cystic Fibrosis, Health Disparities, Minority Inclusion In Clinical Trials, Diversity In Research, Hispanic Latino Health, Pediatric Lung Diseases, Health Equality, Clinical Pharmacology, Asthma, Cystic Fibrosis Transmembrane Conductance Regulator, Personalized Medicine, Lung Function, Pulmonary Function, Cystic Fibrosis Related Diabetes, N of 1 Study

Research

Research Activities and Funding

Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis
NIH/NHLBI K23HL133437Feb 1, 2018 - Jan 31, 2023
Role: Principal Investigator

Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis
Cystic Fibrosis Foundation Jul 1, 2016 - Jun 30, 2019
Role: Primary Investigator

Ivacaftor in non-G551D cystic fibrosis patients
Cystic Fibrosis Foundation, Research Development Program Grant May 1, 2013 - Apr 30, 2015
Role: Co-Investigator

Clinical Pharmacology, Drug Action and Pharmacogenetics
NIH/NIGMS T32GM007546Jul 1, 1977 - Jun 30, 2020
Role: Co-Investigator

ORNG Applications

Featured Publications

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, Davis A, Kumar R, Farber HJ, Meade K, Avila PC, Serebrisky D, Lenoir MA, Brigino-Buenaventura E, Cintron WR, Thyne SM, Rodriguez-Santana JR, Ford JG, Chapela R, Estrada AM, Sandoval K, Seibold MA, Winkler CA, Bleecker ER, Myers DA, Williams LK, Hernandez RD, Torgerson DG, Burchard EG. A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma. Pharmacogenomics J. 2018 Sep 12. PMID: 30206298.

View in: PubMed
Gignoux CR, Torgerson DG, Pino-Yanes M, Uricchio LH, Galanter J, Roth LA, Eng C, Hu D, Nguyen EA, Huntsman S, Mathias RA, Kumar R, Rodriguez-Santana J, Thakur N, Oh SS, McGarry M, Moreno-Estrada A, Sandoval K, Winkler CA, Seibold MA, Padhukasahasram B, Conti DV, Farber HJ, Avila P, Brigino-Buenaventura E, Lenoir M, Meade K, Serebrisky D, Borrell LN, Rodriguez-Cintron W, Thyne S, Joubert BR, Romieu I, Levin AM, Sienra-Monge JJ, Del Rio-Navarro BE, Gan W, Raby BA, Weiss ST, Bleecker E, Meyers DA, Martinez FJ, Gauderman WJ, Gilliland F, London SJ, Bustamante CD, Nicolae DL, Ober C, Sen S, Barnes K, Williams LK, Hernandez RD, Burchard EG. An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos. J Allergy Clin Immunol. 2018 Sep 07. PMID: 30201514.

View in: PubMed
McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP. Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. Pediatr Pulmonol. 2017 Dec; 52(12):1550-1557. PMID: 29082671.

View in: PubMed
McGarry ME, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW. In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies. Pediatr Pulmonol. 2017 Apr; 52(4):472-479. PMID: 28068001.

View in: PubMed
Oh SS, Du R, Zeiger AM, McGarry ME, Hu D, Thakur N, Pino-Yanes M, Galanter JM, Eng C, Nishimura KK, Huntsman S, Farber HJ, Meade K, Avila P, Serebrisky D, Bibbins-Domingo K, Lenoir MA, Ford JG, Brigino-Buenaventura E, Rodriguez-Cintron W, Thyne SM, Sen S, Rodriguez-Santana JR, Williams K, Kumar R, Burchard EG. Breastfeeding associated with higher lung function in African American youths with asthma. J Asthma. 2017 Oct; 54(8):856-865. PMID: 27929698.

View in: PubMed
McGarry ME, McColley SA. Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis. Ann Am Thorac Soc. 2016 Oct; 13(10):1721-1725. PMID: 27410177.

View in: PubMed
McGarry ME, Castellanos E, Thakur N, Oh SS, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, Thyne SM, Sen S, Rodriguez-Santana JR, Borrell LN, Burchard EG. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest. 2015 Jun; 147(6):1591-1598. PMID: 25742612; PMCID: PMC4451713.

View in: PubMed, PubMed Central
Thakur N, McGarry ME, Oh SS, Galanter JM, Finn PW, Burchard EG. The lung corps' approach to reducing health disparities in respiratory disease. Ann Am Thorac Soc. 2014 May; 11(4):655-60. PMID: 24697756; PMCID: PMC4225795.

View in: PubMed, PubMed Central
McGarry ME, Nielson DW. Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N. Chest. 2013 Oct; 144(4):e1-e4. PMID: 24081349; PMCID: PMC4502741.

View in: PubMed, PubMed Central